Sign in
Taking people in United StatesNo phase

Feasibility of Endovascular Repair Of Ascending Aortic Pathologies

Key facts

Who runs it
Rodney A. White, MD
Where
Long Beach, Los Angeles, and Torrance, United StatesSee the 3 sites
Trial code
Status
Recruiting
People taking part
20 people, planned
Started
Nov 2013
Expected to end
Dec 2033
Type of study
Interventional
Treatments tested
  • Endovascular repair with Valiant PS-IDE Stent Graft
Record updated
6 May 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patient must have a Type A thoracic aortic dissection, retrograde Type A thoracic aortic dissection, intramural hematoma, penetrating ulcer or pseudoaneurysm of the ascending thoracic aorta affecting the area between the Sinus of Valsalva and the innominate artery orifice (with no involvement of the aortic valve) and be considered candidates for endovascular repair
  • Patient must also have at least one cm proximal and distal landing zones in the ascending aorta between 28-44 mm in diameter
  • The patient must be deemed high-risk surgical candidate according to the following established criteria: ASA (American Society of Anesthesiologists) class IV

Who cannot take part

  • Patients who have a condition that threatens to infect the stent graft/aortic valve prosthesis
  • Patients with allergies to the stent graft material
  • Pregnant or pediatric patients (younger than 21 years of age)
  • Patients or their legally authorized representatives who do not sign the informed consent
  • Patients with expected survival less than one year

Where in United States

  • Long Beach Memorial Medical CenterLong Beach, United StatesContact: Rodney A White, MDTaking people
  • Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Rodney A White, M.D.No longer taking part
  • LAC Harbor-UCLA Medical CenterTorrance, United StatesContact: Rodney A White, MD (principal investigator)Taking people

About the trial

What the trial wants to find out

The purpose of this study is to investigate the outcome of patients with pathologies of the ascending thoracic aorta (diseases in the great blood vessel or artery that leads away from the heart) including type A aortic dissection, retrograde type A aortic dissection, intramural hematoma, penetrating ulcer or pseudoaneurysm who are suitable for endovascular (within the vessel) repair with the Medtronic Valiant PS-IDE (Physician Sponsored-Investigational Device Exemption) Stent Graft. Type A aortic dissection is a condition where blood passes through the inner lining or between the layers of the blood vessel from a tear in the aortic wall (dissection) in the ascending aorta; a retrograde Type A aortic dissection is a condition where the dissection or tear in the ascending aorta starts from the descending aorta; an intramural hematoma is a collection of clotted blood within the aortic wall; a penetrating ulcer has a plaque or clot within the wall and a pseudoaneurysm is a false aneurysm . If left untreated in any of these conditions, the aorta can enlarge and rupture causing injury or death. The plan for these patients is to repair the ascending thoracic aorta using the Medtronic Valiant PS-IDE Stent Graft with the Captivia Delivery System. The Valiant Captivia has been evaluated worldwide and used extensively in patients with type B (descending) thoracic aortic dissection. Since the dissections in the ascending aortas mirror that of the descending aorta, it is expected that this stent graft will deliver similar performance and endurance in patients with type A aortic dissection. The investigators expect to reroute the blood to the true lumen (the inner space within the blood vessel) by covering the proximal (nearest to the heart) tear with the stent graft. The stent graft is a stent frame made from Nitinol wire and covered with an expandable material made of a polyester material. This new study will determine how well the device works to treat dissections, intramural hematomas, penetrating ulcers and pseudoaneurysms in the ascending thoracic aorta.

The group in the trial

  • Endovascular repair of ascending aortaTreatment being tested

    Endovascular repair with Valiant PS-IDE Stent Graft

    Treatment: Endovascular repair with Valiant PS-IDE Stent Graft

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Proposed Single Center Investigational Device Exemption: Feasibility of Endovascular Repair Of Ascending Aortic Pathologies
Record updated
6 May 2025